List of Intarcia Therapeutics patents

Patents where

Current Assignee

Name

Intarcia Therapeutics

Name	Description	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8460694 Solvent/polymer solutions as suspension vehicles	Patent 8460694 was granted and assigned to Intarcia Therapeutics on June, 2013 by the United States Patent and Trademark Office.	Intarcia Therapeutics	United States Patent and Trademark Office	8460694	June 11, 2013
‌ US Patent 8211467 Osmotic drug delivery devices containing suspension formulations comprising particles having active agents and nonaqueous single-phase vehicles	Patent 8211467 was granted and assigned to Intarcia Therapeutics on July, 2012 by the United States Patent and Trademark Office.	Intarcia Therapeutics	United States Patent and Trademark Office	8211467	July 3, 2012
‌ US Patent 8440226 Solvent/polymer solutions as suspension vehicles	Patent 8440226 was granted and assigned to Intarcia Therapeutics on May, 2013 by the United States Patent and Trademark Office.	Intarcia Therapeutics	United States Patent and Trademark Office	8440226	May 14, 2013
‌ US Patent 7879028 Osmotic delivery systems and piston assemblies for use therein	Patent 7879028 was granted and assigned to Intarcia Therapeutics on February, 2011 by the United States Patent and Trademark Office.	Intarcia Therapeutics	United States Patent and Trademark Office	7879028	February 1, 2011
‌ US Patent 7682356 Osmotic delivery systems and piston assemblies for use therein	Patent 7682356 was granted and assigned to Intarcia Therapeutics on March, 2010 by the United States Patent and Trademark Office.	Intarcia Therapeutics	United States Patent and Trademark Office	7682356	March 23, 2010
‌ US Patent 8206745 Solvent/polymer solutions as suspension vehicles	Patent 8206745 was granted and assigned to Intarcia Therapeutics on June, 2012 by the United States Patent and Trademark Office.	Intarcia Therapeutics	United States Patent and Trademark Office	8206745	June 26, 2012
‌ US Patent 8114437 Solvent/polymer solutions as suspension vehicles	Patent 8114437 was granted and assigned to Intarcia Therapeutics on February, 2012 by the United States Patent and Trademark Office.	Intarcia Therapeutics	United States Patent and Trademark Office	8114437	February 14, 2012
‌ US Patent 8343140 Devices, formulations, and methods for delivery of multiple beneficial agents	Patent 8343140 was granted and assigned to Intarcia Therapeutics on January, 2013 by the United States Patent and Trademark Office.	Intarcia Therapeutics	United States Patent and Trademark Office	8343140	January 1, 2013
‌ US Patent 7727519 Method for treating hepatitis C virus with omega interferon	Patent 7727519 was granted and assigned to Intarcia Therapeutics on June, 2010 by the United States Patent and Trademark Office.	Intarcia Therapeutics	United States Patent and Trademark Office	7727519	June 1, 2010
‌ US Patent 7407499 Osmotic pump with self-retaining, fast-start membrane plug	Patent 7407499 was granted and assigned to Intarcia Therapeutics on August, 2008 by the United States Patent and Trademark Office.	Intarcia Therapeutics	United States Patent and Trademark Office	7407499	August 5, 2008
‌ US Patent 7919109 Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles	Patent 7919109 was granted and assigned to Intarcia Therapeutics on April, 2011 by the United States Patent and Trademark Office.	Intarcia Therapeutics	United States Patent and Trademark Office	7919109	April 5, 2011
‌ US Patent 8372424 Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles	Patent 8372424 was granted and assigned to Intarcia Therapeutics on February, 2013 by the United States Patent and Trademark Office.	Intarcia Therapeutics	United States Patent and Trademark Office	8372424	February 12, 2013
‌ US Patent 8048438 Stable non- aqueous single phase viscous vehicles and formulations utilizing such vehicles	Patent 8048438 was granted and assigned to Intarcia Therapeutics on November, 2011 by the United States Patent and Trademark Office.	Intarcia Therapeutics	United States Patent and Trademark Office	8048438	November 1, 2011
‌ US Patent 8173150 Stable non-aqueous single phase viscous vehicles and formulations utlizing such vehicles	Patent 8173150 was granted and assigned to Intarcia Therapeutics on May, 2012 by the United States Patent and Trademark Office.	Intarcia Therapeutics	United States Patent and Trademark Office	8173150	May 8, 2012
‌ US Patent 7655254 Implantable device for continuous delivery of interferon	Patent 7655254 was granted and assigned to Intarcia Therapeutics on February, 2010 by the United States Patent and Trademark Office.	Intarcia Therapeutics	United States Patent and Trademark Office	7655254	February 2, 2010
‌ US Patent 7655257 Sustained delivery of an active agent using an implantable system	Patent 7655257 was granted and assigned to Intarcia Therapeutics on February, 2010 by the United States Patent and Trademark Office.	Intarcia Therapeutics	United States Patent and Trademark Office	7655257	February 2, 2010
‌ US Patent 8052996 Two-piece, internal-channel osmotic delivery system flow modulator	Patent 8052996 was granted and assigned to Intarcia Therapeutics on November, 2011 by the United States Patent and Trademark Office.	Intarcia Therapeutics	United States Patent and Trademark Office	8052996	November 8, 2011
‌ US Patent 8158150 Two-piece, internal-channel osmotic delivery system flow modulator	Patent 8158150 was granted and assigned to Intarcia Therapeutics on April, 2012 by the United States Patent and Trademark Office.	Intarcia Therapeutics	United States Patent and Trademark Office	8158150	April 17, 2012
‌ US Patent 8367095 Two-piece, internal-channel osmotic delivery system flow modulator	Patent 8367095 was granted and assigned to Intarcia Therapeutics on February, 2013 by the United States Patent and Trademark Office.	Intarcia Therapeutics	United States Patent and Trademark Office	8367095	February 5, 2013
‌ US Patent 8470353 Two-piece, internal-channel osmotic delivery system flow modulator	Patent 8470353 was granted and assigned to Intarcia Therapeutics on June, 2013 by the United States Patent and Trademark Office.	Intarcia Therapeutics	United States Patent and Trademark Office	8470353	June 25, 2013
‌ US Patent 7959938 Polyoxaester suspending vehicles for use with implantable delivery systems	Patent 7959938 was granted and assigned to Intarcia Therapeutics on June, 2011 by the United States Patent and Trademark Office.	Intarcia Therapeutics	United States Patent and Trademark Office	7959938	June 14, 2011
‌ US Patent 8114430 Polyoxaester suspending vehicles for use with implantable delivery systems	Patent 8114430 was granted and assigned to Intarcia Therapeutics on February, 2012 by the United States Patent and Trademark Office.	Intarcia Therapeutics	United States Patent and Trademark Office	8114430	February 14, 2012
‌ US Patent 8257691 Composition and dosage form comprising a particle formulation and suspending vehicle	Patent 8257691 was granted and assigned to Intarcia Therapeutics on September, 2012 by the United States Patent and Trademark Office.	Intarcia Therapeutics	United States Patent and Trademark Office	8257691	September 4, 2012
‌ US Patent 8398967 Particle formulations for use in pharmaceutical compositions	Patent 8398967 was granted and assigned to Intarcia Therapeutics on March, 2013 by the United States Patent and Trademark Office.	Intarcia Therapeutics	United States Patent and Trademark Office	8398967	March 19, 2013
‌ US Patent 7964183 Composition and dosage form comprising a particle formulation and suspending vehicle	Patent 7964183 was granted and assigned to Intarcia Therapeutics on June, 2011 by the United States Patent and Trademark Office.	Intarcia Therapeutics	United States Patent and Trademark Office	7964183	June 21, 2011

Results per page:

34 results

0 selected

34 results

0 selected